E Fund Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-9,252
Closed -$478K 361
2022
Q3
$478K Sell
9,252
-8,228
-47% -$340K 0.04% 133
2022
Q2
$433K Buy
17,480
+6,171
+55% +$136K 0.04% 173
2022
Q1
$284K Buy
+11,309
New +$318K 0.01% 217
2021
Q4
Sell
-11,179
Closed -$191K 318
2021
Q3
$191K Buy
+11,179
New +$174K 0.01% 235

Other funds holding CCXI

E Fund Management's CCXI Position: Q4 2022 in Review

E Fund Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 9,252 shares — an estimated $478K sold.

E Fund Management first reported a position in CCXI in Q3 2021 and held it in 4 quarters. The position peaked at $478K in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • E Fund Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • E Fund Management sold 9,252 ChemoCentryx, Inc. shares in Q4 2022, an estimated $478K.
  • E Fund Management first reported a position in ChemoCentryx, Inc. in Q3 2021 and held it in 4 quarters.
  • E Fund Management's ChemoCentryx, Inc. position peaked at $478K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on E Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.